Virtu Financial’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.27M | Buy |
449,092
+415,056
| +1,219% | +$2.1M | 0.12% | 146 |
|
|
2025
Q1 | $180K | Buy |
+34,036
| New | +$180K | 0.01% | 837 |
|
|
2024
Q4 | – | Sell |
-37,512
| Closed | -$247K | – | 1989 |
|
|
2024
Q3 | $247K | Sell |
37,512
-17,014
| -31% | -$112K | 0.01% | 713 |
|
|
2024
Q2 | $409K | Sell |
54,526
-11,915
| -18% | -$89.4K | 0.03% | 498 |
|
|
2024
Q1 | $662K | Buy |
+66,441
| New | +$662K | 0.05% | 333 |
|
|
2023
Q3 | – | Sell |
-27,205
| Closed | -$203K | – | 1812 |
|
|
2023
Q2 | $203K | Buy |
+27,205
| New | +$203K | 0.02% | 809 |
|